Stallergenes Greer Ltd - Strategic SWOT Analysis Review

December 2020 | 33 pages | ID: SBE3553A5FA5EN
GlobalData

Abstracts

Stallergenes Greer Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Stallergenes Greer Ltd (Stallergenes Greer), formerly Ares Allergy Holdings plc is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases. The company develops diagnostic tests and products with principal focus on allergies. The company offers treatment for important respiratory diseases, which include severe rhino conjunctivitis and rhinitis, and allergic asthma. Stallergenes Greer provides allergen immunotherapy in various dosage forms including injectable or subcutaneous injections, liquid sublinguals and solid sublinguals. Its research and development activities involve development of candidate products, laboratory research, clinical development and regulatory activities. The company distributes its products to various countries in North America, Europe, Africa; Asia and in Australia. Stallergenes Greer is headquartered in London, the UK.

Stallergenes Greer Ltd Key Recent Developments

Sep 01,2020: Stallergenes Greer’s personalised allergen immunotherapy model encouraged by leading scientists: 'Allergy' journal publishes article
May 18,2020: Stallergenes Greer: Expands supply of subcutaneous products; sustains investment in quality and operational excellence
Oct 17,2019: Stallergenes Greer and Anergis initiate new study to predict efficacy of second-generation allergen immunotherapy
Apr 17,2019: Stallergenes Greer reports continued sales growth in the first quarter 2019
Mar 21,2019: Stallergenes Greer delivers 2018 sales and EBITDA in line with recent outlook

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Stallergenes Greer Ltd - Key Facts
Stallergenes Greer Ltd - Key Employees
Stallergenes Greer Ltd - Key Employee Biographies
Stallergenes Greer Ltd - Major Products and Services
Stallergenes Greer Ltd - History
Stallergenes Greer Ltd - Company Statement
Stallergenes Greer Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Stallergenes Greer Ltd - Business Description
Product Category: Other
Overview
Performance
Product Category: Subcutaneous
Overview
Performance
Product Category: Sublingual
Overview
Performance
Product Category: Veterinary
Overview
Performance
Geographical Segment: International
Performance
Geographical Segment: Northern and Central Europe
Performance
Geographical Segment: Southern Europe
Performance
Geographical Segment: The US
Performance
R&D Overview
Stallergenes Greer Ltd - SWOT Analysis
SWOT Analysis - Overview
Stallergenes Greer Ltd - Strengths
Stallergenes Greer Ltd - Weaknesses
Stallergenes Greer Ltd - Opportunities
Stallergenes Greer Ltd - Threats
Stallergenes Greer Ltd - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Stallergenes Greer Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Stallergenes Greer Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Stallergenes Greer Ltd, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Sep 01, 2020: Stallergenes Greer’s personalised allergen immunotherapy model encouraged by leading scientists: 'Allergy' journal publishes article
May 18, 2020: Stallergenes Greer: Expands supply of subcutaneous products; sustains investment in quality and operational excellence
Oct 17, 2019: Stallergenes Greer and Anergis initiate new study to predict efficacy of second-generation allergen immunotherapy
Apr 17, 2019: Stallergenes Greer reports continued sales growth in the first quarter 2019
Mar 21, 2019: Stallergenes Greer delivers 2018 sales and EBITDA in line with recent outlook
Feb 13, 2019: Stallergenes Greer delivers 2018 sales in line with outlook

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Stallergenes Greer Ltd, Key Facts
Stallergenes Greer Ltd, Key Employees
Stallergenes Greer Ltd, Key Employee Biographies
Stallergenes Greer Ltd, Major Products and Services
Stallergenes Greer Ltd, History
Stallergenes Greer Ltd, Subsidiaries
Stallergenes Greer Ltd, Key Competitors
Stallergenes Greer Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Stallergenes Greer Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Stallergenes Greer Ltd, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Stallergenes Greer Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Stallergenes Greer Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020